Clinical Trials Directory

Trials / Conditions / Grass Pollen Allergy

Grass Pollen Allergy

12 registered clinical trials studyying Grass Pollen Allergy2 currently recruiting.

StatusTrialSponsorPhase
RecruitingGRASS (Grass MATA MPL Real-world Assessment Study)
NCT07412990
Allergy Therapeutics
RecruitingCreating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study
NCT07055542
University of MelbourneN/A
CompletedA Motivation-enhancing App to Retain Patients With Hay Fever in a Trial After Treatment
NCT05560698
University of AarhusN/A
CompletedGrass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction
NCT04502966
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2
CompletedDiagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy
NCT04435678
MacroArray Diagnostics GmbHN/A
CompletedPhase II Study of Grass Pollen Allergy Vaccine BM32
NCT01538979
Biomay AGPhase 2
CompletedRegulatory T-cells After Subcutaneous Immunotherapy
NCT01830673
Johann Wolfgang Goethe University Hospital
CompletedSafety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy
NCT01445002
Biomay AGPhase 2
CompletedClinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis
NCT01308021
BioTech Tools S.A.Phase 2
CompletedA Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment
NCT00773240
ALK-Abelló A/SPhase 3
CompletedSafety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture
NCT00264459
Allergopharma GmbH & Co. KGPhase 3
CompletedSafety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis
NCT00263601
Allergopharma GmbH & Co. KGPhase 3